Optimal Timing for Hormone Assessment in Women
For reproductive hormone evaluation in regularly menstruating women not on exogenous hormones, measure FSH and estradiol on cycle days 2-3 (early follicular phase), progesterone on cycle days 19-23 (mid-luteal phase, ideally days 25-26), and testosterone/androgens on either follicular or luteal phase as timing has minimal impact.
Algorithmic Approach by Hormone
FSH and Estradiol
- Draw on cycle days 2-3 (early follicular phase) 1
- This timing provides the most clinically relevant baseline assessment
- FSH is particularly important for ovarian reserve evaluation and should be measured when not suppressed by estradiol or inhibin
- The guideline for functional hypothalamic amenorrhea specifically recommends obtaining FSH and estradiol as part of initial endocrine evaluation 1
Progesterone
- Draw on cycle days 19-23 (mid-luteal phase), with optimal timing on days 25-26 2
- Days 25-26 provide the highest diagnostic accuracy (sensitivity 81%, specificity 73%) with a discriminatory level of 21 nmol/L 2
- Research shows the most consistent correlation for progesterone occurs between days 17-21 (r=0.80) 3
- This timing is critical for assessing luteal phase adequacy
LH
- Draw on cycle days 2-3 (early follicular phase) 1
- Can be drawn simultaneously with FSH and estradiol
- Note that LH/FSH ratio varies significantly between follicular (0.2-1.7) and luteal phases (0.3-3.5), so timing matters 4
Testosterone and Androgens
- Timing is less critical - can be drawn in either follicular or luteal phase 4
- While testosterone and SHBG show slightly higher mean values in luteal phase, androgen concentrations and calculated indexes remain equal between phases 4
- The guideline recommends obtaining total testosterone in patients with clinical hyperandrogenism 1
- Free androgen index shows most consistent correlation on days 12-15 if precise characterization needed 3
Important Clinical Caveats
Age considerations: FSH concentrations begin rising significantly from age 39 onward (approximately 3-fold higher by ages 48-50), predominantly during mid-follicular and post-ovulatory phases when inhibin is minimal 5. This must be factored into interpretation.
Cycle day counting: All recommendations assume counting from the first day of menstrual bleeding as day 1. For progesterone specifically, counting backward from the next expected menses may provide marginally stronger associations 3.
Time of day: Blood should be collected in the morning (ideally around 8 AM) as reproductive hormones exhibit circadian rhythms with acrophases varying by hormone - E2 peaks at night, FSH/LH/SHBG in afternoon, progesterone in morning 6.
When Timing Cannot Be Controlled
If a woman presents with amenorrhea or oligomenorrhea (cycle intervals >45 days), proceed with hormone evaluation without waiting for specific cycle timing 1. The diagnostic workup should include pregnancy test, TSH, free T4, prolactin, LH, FSH, estradiol, and AMH 1.